These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6194881

  • 21. What can we learn from phase II adjuvant trials in melanoma?
    Keilholz U, Suciu S, Eggermont AM.
    Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
    [No Abstract] [Full Text] [Related]

  • 22. Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.
    Morton RF, Creagan ET, Veeder MH, Elson DL, Laurie JA, Nelimark RA, Chang MN.
    Cancer Treat Rep; 1987 Apr; 71(4):429-30. PubMed ID: 3548962
    [No Abstract] [Full Text] [Related]

  • 23. Combination chemotherapy of metastatic melanoma.
    Berd D, Mastrangelo MJ.
    J Clin Oncol; 1995 Mar; 13(3):796-7. PubMed ID: 7884439
    [No Abstract] [Full Text] [Related]

  • 24. Systemic chemotherapy in the treatment of malignant melanoma.
    Lens MB, Eisen TG.
    Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
    [Abstract] [Full Text] [Related]

  • 25. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ, Braybrooke JP, Levitt NC, O'Byrne K, Christodoulos K, Han C, Talbot DC, Ganesan TS, Harris AL.
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [Abstract] [Full Text] [Related]

  • 26. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Al-Jamal RT, Eskelin S, Pyrhönen S, Kivelä T.
    Acta Oncol; 2009 Jun; 48(3):476-9. PubMed ID: 19031163
    [No Abstract] [Full Text] [Related]

  • 27. [Marked regression of melanoma metastases under combined chemotherapy].
    Klemm-Mayer H, Rasokat H, Wagner G.
    Z Hautkr; 1984 Apr 01; 59(7):443-5. PubMed ID: 6730608
    [Abstract] [Full Text] [Related]

  • 28. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
    Carmo-Pereira J, Oliveira Costa F, Pimentel P.
    Cancer Treat Rep; 1976 Sep 01; 60(9):1381-3. PubMed ID: 1016972
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study.
    Jelić S, Babovic N, Kovcin V, Milicevic N, Milanovic N, Popov I, Radosavljevic D.
    Melanoma Res; 2002 Feb 01; 12(1):91-8. PubMed ID: 11828263
    [Abstract] [Full Text] [Related]

  • 30. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
    Thompson JA, Gold PJ, Fefer A.
    Semin Oncol; 1997 Feb 01; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
    [Abstract] [Full Text] [Related]

  • 31. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
    Maeda K, Miura S, Kawamura M, Jimbow K.
    Gan To Kagaku Ryoho; 1984 Nov 01; 11(11):2434-7. PubMed ID: 6497401
    [Abstract] [Full Text] [Related]

  • 32. Phase II study: the combination DTIC, BCNU, actinomycin D, and vincristine in disseminated malignant melanoma.
    Creagan ET, Schutt AJ, Long HJ, Green SJ.
    Med Pediatr Oncol; 1986 Nov 01; 14(2):86-7. PubMed ID: 3713642
    [Abstract] [Full Text] [Related]

  • 33. DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine.
    Hill GJ, Metter GE, Krementz ET, Fletcher WS, Golomb FM, Ramirez G, Grage TB, Moss SE.
    Cancer Treat Rep; 1979 Nov 01; 63(11-12):1989-92. PubMed ID: 393384
    [No Abstract] [Full Text] [Related]

  • 34. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
    Ott PA, Chang JL, Oratz R, Jones A, Farrell K, Muggia F, Pavlick AC.
    Chemotherapy; 2009 Nov 01; 55(4):221-7. PubMed ID: 19451711
    [Abstract] [Full Text] [Related]

  • 35. [Primary malignant melanoma of the female urethra: a case report].
    Kajikawa H, Takada M, Seguchi T, Sakaguchi H.
    Hinyokika Kiyo; 1987 Jan 01; 33(1):97-100. PubMed ID: 2437781
    [Abstract] [Full Text] [Related]

  • 36. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
    Kawada K, Kawano T, Nagai K, Nishikage T, Nakajima Y, Tokairin Y, Ogiya K, Tanaka K, Iwai T.
    Gastrointest Endosc; 2007 Aug 01; 66(2):408-10. PubMed ID: 17643724
    [No Abstract] [Full Text] [Related]

  • 37. Treatment and prognosis of malignant melanoma of the oral cavity: preoperative surgical procedure increases risk of distant metastasis.
    Umeda M, Komatsubara H, Shigeta T, Ojima Y, Minamikawa T, Shibuya Y, Yokoo S, Komori T.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul 01; 106(1):51-7. PubMed ID: 18504155
    [Abstract] [Full Text] [Related]

  • 38. Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma.
    Reinhold U, Bruske T, Kreysel HW.
    Eur J Cancer; 1996 Jan 01; 32A(1):180. PubMed ID: 8695233
    [No Abstract] [Full Text] [Related]

  • 39. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L, Helmbold P, Emmert S, Marsch WC.
    Hautarzt; 2002 Aug 01; 53(8):536-41. PubMed ID: 12221468
    [Abstract] [Full Text] [Related]

  • 40. Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma.
    Abele R, Bernheim J, Cumps E, Buyse M, Kenis Y.
    Cancer Treat Rep; 1981 Aug 01; 65(5-6):505-6. PubMed ID: 6165474
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.